Results

Total Results: 1,613 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse eventsadverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverseevents: 4.65% (10/215) vs.
  2. effectivehealthcare.ahrq.gov/products/childhood-depression/protocol
    August 24, 2018 - All guidelines suggest active monitoring for potential adverse events and ensuring that the treatment … Adverse events may occur at any point after the treatment is received. IV. … events) All other outcomes Time frame Any publication dates At least 6 weeks of … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome" … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome"
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - with acute coronary syndrome, (2) patients who have suffered other cardiovascular disease-related events … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and … for clinical outcomes among patients receiving clopidogrel treatment for the prevention of major adverse … cardiovascular events? … guiding treatment choice for patients who require antiplatelet therapy for the prevention of major adverse
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
    March 01, 2024 - • The identified diagnostic studies did not assess the adverse effects of being labeled correctly … events … Furthermore, the identified studies did not assess the adverse effects of being labeled correctly or … events, such as appetite suppression (RR 0.82; CI 0.53, 1.26, 8 studies, n=1463; low SoE). … Across studies, medication therapy evaluations reported more adverse events than non-medication interventions
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/inguinal-hernia_executive.pdf
    August 01, 2012 - events? … events? … Do different mesh products differ in patient-oriented effectiveness outcomes and/or adverse events? … events? … For adverse events and pain reported dichotomously, we analyzed ORs.
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-surveillance-report-3.pdf
    May 01, 2022 - , nausea, sedation) and study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … a Other serious adverse events (i.e., psychosis and cannabis use disorder) not reported in any study. … ; VAS = visual analog scale; WAE = withdrawal due to due adverse events. … scale; WAE = withdrawal due to due adverse events.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - Adverse events: • What adverse effects are related to n-3 FA intake (in studies of CVD outcomes and … stroke, transient ischemic attack, unstable angina, major adverse CV events [MACE]; total events include … events) • Prospective nonrandomized comparative studies (clinical outcomes, adverse events) • Prospective … • No serious or severe adverse events were related to n-3 FA intake (supplementation). … differences in serious or nonserious adverse events between marine oil and placebo.
  8. effectivehealthcare.ahrq.gov/products/back-pain-treatment/clinician
    November 15, 2016 - Adverse Effects For nonpharmacological therapies, assessment of harms was suboptimal. … Pharmacological therapies are associated with increased risk of adverse events when compared with placebo … Examples of reported adverse effects included mild bleeding at needling sites with acupuncture, skin … Pharmacological Pharmacological therapies were associated with increased risk of adverse events when … addiction, overdose, and death Nonsteroidal anti-inflammatory drugs Cardiovascular thrombotic events
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
    February 01, 2008 - events such as neurological adverse effects, hypotension, rash, suicidal ideation, mood and cognition … Based on the comments received and input from the Technical Expert Panel, the adverse events listed … effects • Cosmetic adverse events • Incidence of adverse events • Incidence of individual adverseevents • Incidence of adverse events resulting in therapy withdrawal • Incidence of adverse events … not resulting in therapy withdrawal • Skin rash • Neurological adverse events • Suicidal ideation
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
    August 06, 2018 - events (AEs); that is, some interventions Source: www.effectivehealthcare.ahrq.gov Published … All guidelines suggest active monitoring for potential adverse events and ensuring that the treatment … Adverse events may occur at any point after the treatment is received. IV. … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome
  11. effectivehealthcare.ahrq.gov/products/antibiotics-respiratory-infection/clinician
    April 06, 2016 - This is a summary of a systematic review evaluating the evidence regarding the effectiveness and adverse … drug events. … events ( [evidence low] ). … No evidence was found regarding the effect of the combination on adverse consequences. … comparative benefits and adverse consequences.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
    June 29, 2019 - events in older adults are shown in green. … events, misuse, or opioid use disorder)? … b. reduce the risk of adverse events, misuse or opioid use disorder in older adults for whom opioids … events. … Reducing the risk of adverse drug events in older adults.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - No serious adverse events, death, or withdrawal due to adverse events were reported. 8 A subgroup … No serious adverse events or withdrawal due to adverse events were reported. … No adverse events were reported in either groups. … No serious adverse events, death, and withdrawal due to adverse events were reported. … No significant adverse events were reported.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-cardio-dental.pdf
    July 01, 2023 - Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion … Events in Those Undergoing Insertion of Implantable Cardiovascular Devices Main Points … events following VAD insertion. … Pre-Cardiac Dental Treatment Does Not Increase the Risk of Adverse Events. … Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration: 6 weeks University … to study medications: 12.7% (7/55) vs. 29.1% (16/55), RR 0.44 (95% CI 0.20 to 0.98) Serious AEs: No events … B (events/total person-years); adjusted Incidence Rate Ratio (aIRR): Overdose: 3241/22097 vs. 11433/ … cardiovascular events (including ischemic heart disease, congestive heart failure, acute ischemic stroke … B Major adverse cardiovascular events: 52 vs. 72 Incidence rate per 10,000 person months (95% CI): 30.12
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
    April 01, 2014 - For Key Question 2 we considered the following prespecified adverse events (harms): nausea; vomiting … severity of patient-reported adverse events (nausea, vomiting, fatigue, bloating, cramping, etc.). … Almost universally, the rates of reported adverse events were below 4 percent. … No studies reported adverse events by any of the prespecified subgroups of interest. … Hartmann's reversal is associated with high postoperative adverse events.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - reports, adverse events associated with discontinuation of treatment, and serious adverse events … • Withdrawals from study and discontinuation of treatment due to adverse events • All-cause mortality … events, discontinuation due to adverse events, and weight gain. … events Insufficient; no conclusions drawn Sertraline Sertraline + interpersonal psychotherapy Adverse … therapy Adverse events Insufficient; SSRI = selective serotonin reuptake inhibitor, TCA = tricyclic
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
    January 01, 2009 - events. … events. … drug events, no response) Events rates markedly different than in community Event rates in treatment … events) was chosen. … events.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
    January 01, 2007 - blood pressure control, preservation of kidney function, flash pulmonary edema, other cardiovascular events … What adverse events and complications have been associated with aggressive medical therapy or renal artery … • There is weak evidence suggesting similar rates of cardiovascular events between interventions; however … , it is likely that the studies were too small to detect different rates of cardiovascular events … • The evidence does not adequately assess comparisons of adverse events between medical treatment
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - Peer Reviewer #3 Results (Pg 52) One reason for the low adverse events rate in the etanercept studies … are the active run-in periods that excluded children who had adverse events. … During the double-blind phase (Period B), serious adverse events occurred in two patients in the placebo … Acute infusional adverse events were reported in one (2%) patient in the abatacept group and two (3% … The adverse events data from that study are included in the Appendix.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: